RECEIVER SENSITIVITY Sample Clauses

RECEIVER SENSITIVITY. Base Station receiver sensitivity shall be measured at the Base Station site equipment level. Antenna, connector or cable losses are not included as part of this measurement. Mast mount or external Low Noise Amplifier (LNA) equipment shall not be included as part of, or included with, this measurement. Lightning suppression devices which contribute loss to these systems will be included if this suppression device is located at or with the Base Station site equipment. Mast mount or coax line feed installed suppression devices will be included in the antenna / coax feed loss budget. Sensitivity measurements shall include any internal cell sites equipment internal (e.g., LNA, frequency selective components such as band pass or band reject filters, and receiver path signal).
Sample 1Sample 2
AutoNDA by SimpleDocs
RECEIVER SENSITIVITY. Receiver sensitivity shall be compliant with PN3383, (Draft American National Standard or Telecommunications - Recommended Minimum Performance Requirement for Base Stations Supporting 1.8 to 2.0 GHz Code Division Multiple Access (CDMA) Personal Stations) with the following clarification / exceptions. Baud rate = 14.4 kbps Item 2 in section 3.4.1.2 Method of Measurements should be amended to read
Sample 1Sample 2
RECEIVER SENSITIVITY. The typical received input RF power (measured at the antenna output port) to achieve a decoded [***] shall be as shown in the table below. The receiver sensitivity for a decoded BER of [***] is nominally [***] dB higher than for [***]. Table 3-3: Receiver Sensitivity BANDWIDTH (MHZ) 4 QAM (DBM) 16 QAM (DBM) --------------- ---------------------- ---------------------- Typical Maximum Typical Maximum ------- ------- ------- ------- 10.0 [***] [***] [***] [***] [***] 12.5 [***] [***] [***] [***] 20.0 [***] [***] [***] [***] [***] 25.0 [***] [***] [***] [***] [***]
Sample 1Sample 2
RECEIVER SENSITIVITY. Receiver sensitivity is defined as the RF power at the antenna output in the receiver. For each modulation and coding scheme, receiver is expected to process the signal properly when the incoming signal power is greater than the threshold. Table 1 shows the receiver sensitivity for each modulation and coding scheme. Higher modulation requires higher receiver sensitivity, because higher modulation requires a better SNR. Figure 15 shows a measured signal-to-noise and distortion ratio (SNDR) of received signal with various received power. The gray line describes the required SNDR for each MCSs. For example, at −61 dB, which is receiver sensitivity of MCS 0, required SNDR for stable transfer is about 5.7 dB. As seen in Figure 15, current TS2 chip achieves better SNDR compared with the requirements and also see some improvements from previous version of chip, TS1. In this test, the SNDR is obtained by measuring single tone RF signal. So actual SNR of modulated signal will be degraded due to phase noise or RF impairments.
Sample 1
RECEIVER SENSITIVITY. The typical received input RF power (measured at the antenna output port) to achieve a decoded [***] shall be as shown in the table below. The receiver sensitivity for a decoded BER of [***] is nominally [***] dB higher than for [***]. [***] [***] CONFIDENTIAL TREATMENT REQUESTED -7- 61 [***] GHz Point to Multipoint Radio Subsystem Specification
Sample 1
RECEIVER SENSITIVITY 
Sample 1

Related to RECEIVER SENSITIVITY

  • Screening After you sign and date the consent document, you will begin screening. The purpose of the screening is to find out if you meet all of the requirements to take part in the study. Procedures that will be completed during the study (including screening) are described below. If you do not meet the requirements, you will not be able to take part in the study. The study investigator or study staff will explain why. As part of screening, you must complete all of the items listed below: • Give your race, age, gender, and ethnicity • Give your medical history o You must review and confirm the information in your medical history questionnaire • Give your drug, alcohol, and tobacco use history • Give your past and current medication and treatment history. This includes any over-the-counter or prescription drugs, such as vitamins, dietary supplements, or herbal supplements, taken in the past 28 days • Height and weight will be measured • Physical exam will be done • Electrocardiogram (ECG) will be collected. An ECG measures the electrical activity of the heart • You may be tested for COVID-19 o Blood tests for human immunodeficiency virus (HIV), hepatitis B, and hepatitis C o Blood tests to see how your blood clots ▪ Fibrinogen ▪ PT/INR/aPTT o Blood tests for amylase and lipase (enzymes that help with digestion, Part B only) o Blood tests for a lipid (fats) panel (Part B only) ▪ Total cholesterol ▪ Triglycerides ▪ HDL ▪ Direct HDL o Blood tests to check your thyroid function (Part B and Part C only) ▪ TSH ▪ Free T4 o Urine to test for drugs of abuse (illegal and prescription) o Urine tests to check your albumin/ creatinine ratio o Females who have not had a period for at least 12 months in a row will have a blood hormone test to confirm they cannot have children • The study investigator may decide to do an alcohol breath test • The use of proper birth control will be reviewed (males only) • You will be asked “How do you feel?” HIV, hepatitis B, and hepatitis C will be tested at screening. If anyone is exposed to your blood during the study, you will have these tests done again. If you have a positive test, you cannot be in or remain in the study. HIV is the virus that causes acquired immunodeficiency syndrome (AIDS). If your HIV test is positive, you will be told about the results. It may take weeks or months after being infected with HIV for the test to be positive. The HIV test is not always right. Having certain infections or positive test results may have to be reported to the State Department of Health. This includes results for HIV, hepatitis, and other infections. If you have any questions about what information is required to be reported, please ask the study investigator or study staff. Although this testing is meant to be private, complete privacy cannot be guaranteed. For example, it is possible for a court of law to get health or study records without your permission.

  • Searchability Offering searchability capabilities on the Directory Services is optional but if offered by the Registry Operator it shall comply with the specification described in this section. 1.10.1 Registry Operator will offer searchability on the web-­‐based Directory Service. 1.10.2 Registry Operator will offer partial match capabilities, at least, on the following fields: domain name, contacts and registrant’s name, and contact and registrant’s postal address, including all the sub-­‐fields described in EPP (e.g., street, city, state or province, etc.). 1.10.3 Registry Operator will offer exact-­‐match capabilities, at least, on the following fields: registrar id, name server name, and name server’s IP address (only applies to IP addresses stored by the registry, i.e., glue records). 1.10.4 Registry Operator will offer Boolean search capabilities supporting, at least, the following logical operators to join a set of search criteria: AND, OR, NOT. 1.10.5 Search results will include domain names matching the search criteria. 1.10.6 Registry Operator will: 1) implement appropriate measures to avoid abuse of this feature (e.g., permitting access only to legitimate authorized users); and 2) ensure the feature is in compliance with any applicable privacy laws or policies.

  • Court Appearances If an employee is subpoenaed to appear as a witness in a job-related court case, not during the employee’s regularly assigned shift, the employee shall be credited for actual time worked, or a minimum of two and one-half hours, whichever is greater.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!